Related Experiment Video
Updated: May 22, 2025

06:33
Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
7.7K
Cardiac Amyloidosis: How Its Epidemiology is Changing
Giorgia Panichella1, Alberto Aimo2, Giuseppe Vergaro2
1Department of Clinical and Experimental Medicine, University of Florence, Florence 50134, Italy.
Heart Failure Clinics
|March 13, 2025
Summary
Cardiac amyloidosis (CA) involves amyloid buildup in the heart. While immunoglobulin light chain CA is stable, wild-type transthyretin CA is increasing, impacting screening and management.
Area of Science:
- Cardiology
- Genetics
- Epidemiology
Background:
- Cardiac amyloidosis (CA) is a progressive condition caused by amyloid fibril accumulation in the heart.
- It leads to diastolic dysfunction, heart failure, and increased mortality.
- Two main types are immunoglobulin light chain amyloidosis (AL) and transthyretin amyloidosis (ATTR).
Purpose of the Study:
- To review the current epidemiology of cardiac amyloidosis.
- To highlight the increasing incidence and prevalence of wild-type transthyretin CA.
- To discuss the implications for clinical screening and management strategies.
Main Methods:
- Literature review of epidemiological studies on cardiac amyloidosis.
- Analysis of incidence and prevalence data for different CA subtypes.
- Synthesis of findings to inform screening and management.
Main Results:
- Immunoglobulin light chain amyloidosis (AL) incidence is stable at 8-15.2 cases per million persons (PMP)/year.
- Wild-type transthyretin CA incidence is increasing (14-27 cases PMP/year).
- Wild-type transthyretin CA prevalence is estimated at 30-170 cases PMP.
Conclusions:
- The rising prevalence of wild-type transthyretin CA necessitates updated screening protocols.
- Early detection and management are crucial for improving patient outcomes.
- Further research into CA epidemiology is essential for effective public health strategies.
Related Concept Videos
Amyloid Fibrils
9.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.2K
Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K

